Carbonite Closes Acquisition of Webroot

Related Posts

06Nov

eSight 3 Approved on the U.S. Department of Veterans Affairs (VA) Federal Supply Schedule

eSight, a world leader in vision technology, announced the approval of eSight 3 – advanced sight-enhancing glasses for those living... read more
11Dec

Pensacola State College Uses Regroup to Respond to Credible Threat of Dating Violence

Regroup Mass Notification’s emergency alert platform was used by the Pensacola State College's police department to avert potential violence arising... read more
01Feb

Corbus Pharmaceuticals Announces Pricing of Public Offering

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company with a diversified portfolio, today announced the pricing of an underwritten public... read more
26Jul

Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today... read more
05Dec

Inc.’s Best in Business 2023 Companies That Put Purpose Before Profit

Candidly has been named to Inc. Magazine's 2023 Best In Business list, featured in the Financial Services category in recognition... read more
13Nov

Carbonite Inc. (CARB) Breaks into New 52-Week High on November 11 Session

Shares of Carbonite Inc. (CARB) broke into a new 52-week high yesterday, hitting a peak of $17.95. Shares closed at... read more
30Oct

Wasabi Technologies Appoints Jon Howes as Senior Vice President of Global Sales

Wasabi Technologies, the hot cloud storage company, today announced the appointment of Jon Howes as senior vice president of global... read more
29Nov

‘He loves them’: Special e-specs give blind boy a new lease on life

It's a big day for Benny Francey. He's at the library in Selkirk, Man. for the first time with new specs. "I... read more
04Nov

Hoth Therapeutics Announces Positive, Statistically Significant Proof-of-Concept Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease

Hoth Therapeutics, Inc., a biopharmaceutical company, today announced positive, statistically significant proof-of-concept preclinical data on its therapeutic HT-005 for the... read more
22Jul

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced a commercial agreement with Seppic S.A., a... read more